2012
DOI: 10.3109/0886022x.2012.690715
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Hypertension in Dialysis Patients

Abstract: Cardiovascular complications are encountered frequently in end-stage renal disease (ESRD) patients. The study was designed as a prospective cohort study and a total of 105 dialysis patients, 77 hemodialysis and 28 peritoneal dialysis patients, were investigated. All patients had undergone M-Mode Doppler echocardiography every 6 months by which their systolic pulmonary arterial pressures (sPAPs) and left ventricular mass indices (LVMIs) were recorded. Thirty-nine (37.1%) patients had pulmonary hypertension (PHT… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
4
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 27 publications
(42 reference statements)
1
4
0
Order By: Relevance
“…Additionally, diabetes was significantly more prevalent among patients with PAH. In line with our results, previous reports revealed that hypertensive nephropathy was the main underlying cause of nephropathy in which its incidence was significantly different among individuals with and without pulmonary hypertension [9,16,22,23]. One potential reason is that individuals with chronic hypertension often develop left ventricular hypertrophy, and studies have shown a probable link between LVH and an increased risk of PAH [24].…”
Section: Discussionsupporting
confidence: 90%
“…Additionally, diabetes was significantly more prevalent among patients with PAH. In line with our results, previous reports revealed that hypertensive nephropathy was the main underlying cause of nephropathy in which its incidence was significantly different among individuals with and without pulmonary hypertension [9,16,22,23]. One potential reason is that individuals with chronic hypertension often develop left ventricular hypertrophy, and studies have shown a probable link between LVH and an increased risk of PAH [24].…”
Section: Discussionsupporting
confidence: 90%
“…Despite some conflicting results, evidence suggests that anemia can contribute to pulmonary hypertension by aggravating hypoxia and increasing cardiac output in patients with ESRD [ 8 , 9 ]. Interestingly, we observed significantly lower hemoglobin levels in patients with PAH than in those without PAH [ 20 , 29 , 30 ]. The low levels of hemoglobin in HD patients with PAH might be a result of hypervolemia.…”
Section: Discussionmentioning
confidence: 99%
“…However, in most trials, PAP measurements are obtained by Doppler echocardiography due to its noninvasive nature. 2,22,23 In conclusion, the present study indicated that pulmonary hypertension was a common condition in ESRD patients undergoing hemodialysis. However, we were not able to detect a significant association between PAP and the SF-36 domains.…”
Section: Discussionmentioning
confidence: 85%
“…21 Thus, measurement of HRQOL should be included in the general clinical work-up and follow-up of patients on dialysis. 22,23 In this study, we assessed the relation between pulmonary hypertension and HRQOL in patients undergoing hemodialysis. Significant differences were observed among our study groups regarding the physical function, physical role, bodily pain, general health, vitality, social function, emotional role, mental health, and physical component summary.…”
Section: Discussionmentioning
confidence: 99%